SLC7A10 and obesity disorder: In the present review we focus on the HAT SLC7A10, which has a particularly high expression in adipocytes and emerged as an important player in metabolic diseases related to obesity, insulin resistance and type 2 diabetes (Small et al., 2011; Jersin et al., 2021).